(MedPage Today) — Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction autoantibodies, but a wide range of differences among patients affect the clinical management of the disease…
Source link : https://www.medpagetoday.com/spotlight/gmg/114546
Author :
Publish date : 2025-03-07 19:44:00
Copyright for syndicated content belongs to the linked Source.
